Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2017 | Pages:
123 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)
In this report, the EMEA Active Pharmaceutical Ingredients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Active Pharmaceutical Ingredients for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Active Pharmaceutical Ingredients market competition by top manufacturers/players, with Active Pharmaceutical Ingredients sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Novartis International
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
GlaxoSmithKline
Merck & Co
AbbVie
Johnson & Johnson
Bayer
Sun Pharmaceutical Industries
DSM
Hisun Pharmacy
Huahai Pharmaceutical
North China Pharmaceutical Group
Shandong Lukang Pharmaceutical
Haerbin Pharmaceutical Group
Shandong Xinhua Pharmaceutical
Jiangsu Hengrui Medicine
Lonza Group
Aurobindo Pharma
Lupin
Biocon
On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into
Synthetic APIs
Biotech APIs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Active Pharmaceutical Ingredients for each application, including
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Active Pharmaceutical Ingredients Market Report 2017
1 Active Pharmaceutical Ingredients Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients
1.2.1 EMEA Active Pharmaceutical Ingredients Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Active Pharmaceutical Ingredients Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Synthetic APIs
1.2.4 Biotech APIs
1.3 EMEA Active Pharmaceutical Ingredients Market by Application/End Users
1.3.1 EMEA Active Pharmaceutical Ingredients Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Disease
1.3.5 CNS and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Other
1.4 EMEA Active Pharmaceutical Ingredients Market by Region
1.4.1 EMEA Active Pharmaceutical Ingredients Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Active Pharmaceutical Ingredients (2012-2022)
1.5.1 EMEA Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2022)
1.5.2 EMEA Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)
2 EMEA Active Pharmaceutical Ingredients Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Active Pharmaceutical Ingredients Market Competition by Players/Manufacturers
2.1.1 EMEA Active Pharmaceutical Ingredients Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Active Pharmaceutical Ingredients Revenue and Share by Players (2012-2017)
2.1.3 EMEA Active Pharmaceutical Ingredients Sale Price by Players (2012-2017)
2.2 EMEA Active Pharmaceutical Ingredients (Volume and Value) by Type/Product Category
2.2.1 EMEA Active Pharmaceutical Ingredients Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Active Pharmaceutical Ingredients Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Active Pharmaceutical Ingredients Sale Price by Type (2012-2017)
2.3 EMEA Active Pharmaceutical Ingredients (Volume) by Application
2.4 EMEA Active Pharmaceutical Ingredients (Volume and Value) by Region
2.4.1 EMEA Active Pharmaceutical Ingredients Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Active Pharmaceutical Ingredients Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Active Pharmaceutical Ingredients Sales Price by Region (2012-2017)
3 Europe Active Pharmaceutical Ingredients (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Active Pharmaceutical Ingredients Sales and Value (2012-2017)
3.1.1 Europe Active Pharmaceutical Ingredients Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
3.2 Europe Active Pharmaceutical Ingredients Sales and Market Share by Type
3.3 Europe Active Pharmaceutical Ingredients Sales and Market Share by Application
3.4 Europe Active Pharmaceutical Ingredients Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Active Pharmaceutical Ingredients Sales Volume by Countries (2012-2017)
3.4.2 Europe Active Pharmaceutical Ingredients Revenue by Countries (2012-2017)
3.4.3 Germany Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
3.4.4 France Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
3.4.5 UK Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
3.4.6 Russia Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
3.4.7 Italy Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
3.4.8 Benelux Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
4 Middle East Active Pharmaceutical Ingredients (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Active Pharmaceutical Ingredients Sales and Value (2012-2017)
4.1.1 Middle East Active Pharmaceutical Ingredients Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
4.2 Middle East Active Pharmaceutical Ingredients Sales and Market Share by Type
4.3 Middle East Active Pharmaceutical Ingredients Sales and Market Share by Application
4.4 Middle East Active Pharmaceutical Ingredients Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Active Pharmaceutical Ingredients Sales Volume by Countries (2012-2017)
4.4.2 Middle East Active Pharmaceutical Ingredients Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
4.4.4 Israel Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
4.4.5 UAE Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
4.4.6 Iran Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
5 Africa Active Pharmaceutical Ingredients (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Active Pharmaceutical Ingredients Sales and Value (2012-2017)
5.1.1 Africa Active Pharmaceutical Ingredients Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
5.2 Africa Active Pharmaceutical Ingredients Sales and Market Share by Type
5.3 Africa Active Pharmaceutical Ingredients Sales and Market Share by Application
5.4 Africa Active Pharmaceutical Ingredients Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Active Pharmaceutical Ingredients Sales Volume by Countries (2012-2017)
5.4.2 Africa Active Pharmaceutical Ingredients Revenue by Countries (2012-2017)
5.4.3 South Africa Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
5.4.5 Egypt Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
5.4.6 Algeria Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
6 EMEA Active Pharmaceutical Ingredients Manufacturers/Players Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis International
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis International Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Boehringer Ingelheim Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Teva Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Eli Lilly and Company
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Eli Lilly and Company Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GlaxoSmithKline Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck & Co
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck & Co Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 AbbVie
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 AbbVie Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Bayer
6.13 Sun Pharmaceutical Industries
6.14 DSM
6.15 Hisun Pharmacy
6.16 Huahai Pharmaceutical
6.17 North China Pharmaceutical Group
6.18 Shandong Lukang Pharmaceutical
6.19 Haerbin Pharmaceutical Group
6.20 Shandong Xinhua Pharmaceutical
6.21 Jiangsu Hengrui Medicine
6.22 Lonza Group
6.23 Aurobindo Pharma
6.24 Lupin
6.25 Biocon
7 Active Pharmaceutical Ingredients Manufacturing Cost Analysis
7.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Active Pharmaceutical Ingredients Market Forecast (2017-2022)
11.1 EMEA Active Pharmaceutical Ingredients Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Active Pharmaceutical Ingredients Price and Trend Forecast (2017-2022)
11.2 EMEA Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Active Pharmaceutical Ingredients Sales Forecast by Type (2017-2022)
11.7 EMEA Active Pharmaceutical Ingredients Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Active Pharmaceutical Ingredients
Figure EMEA Active Pharmaceutical Ingredients Sales Volume (MT) by Type (2012-2022)
Figure EMEA Active Pharmaceutical Ingredients Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic APIs Product Picture
Figure Biotech APIs Product Picture
Figure EMEA Active Pharmaceutical Ingredients Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Active Pharmaceutical Ingredients by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure CNS and Neurological Disorders Examples
Table Key Downstream Customer in CNS and Neurological Disorders
Figure Endocrinology Examples
Table Key Downstream Customer in Endocrinology
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Active Pharmaceutical Ingredients Market Size (Million USD) by Region (2012-2022)
Figure Europe Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Active Pharmaceutical Ingredients Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Active Pharmaceutical Ingredients Revenue (Million USD) Status and Forecast by Countries
Figure Africa Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Active Pharmaceutical Ingredients Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Active Pharmaceutical Ingredients Sales Volume and Growth Rate (2012-2022)
Figure EMEA Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Active Pharmaceutical Ingredients Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales Share by Players (2012-2017)
Figure 2016 Active Pharmaceutical Ingredients Sales Share by Players
Figure 2017 Active Pharmaceutical Ingredients Sales Share by Players
Figure EMEA Active Pharmaceutical Ingredients Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Revenue (Million USD) by Players (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Revenue Share by Players (2012-2017)
Table 2016 EMEA Active Pharmaceutical Ingredients Revenue Share by Players
Table 2017 EMEA Active Pharmaceutical Ingredients Revenue Share by Players
Table EMEA Active Pharmaceutical Ingredients Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales Share by Type (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Type (2012-2017)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share by Type (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Type in 2016
Table EMEA Active Pharmaceutical Ingredients Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales Share by Application (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Application (2012-2017)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share by Application in 2016
Table EMEA Active Pharmaceutical Ingredients Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales Share by Region (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Region (2012-2017)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share in 2016
Table EMEA Active Pharmaceutical Ingredients Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Region (2012-2017)
Figure EMEA Active Pharmaceutical Ingredients Revenue Market Share Regions in 2016
Table EMEA Active Pharmaceutical Ingredients Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales (MT) by Type (2012-2017)
Table Europe Active Pharmaceutical Ingredients Market Share by Type (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Market Share by Type in 2016
Table Europe Active Pharmaceutical Ingredients Sales (MT) by Application (2012-2017)
Table Europe Active Pharmaceutical Ingredients Market Share by Application (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Market Share by Application in 2016
Table Europe Active Pharmaceutical Ingredients Sales (MT) by Countries (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales Market Share by Countries (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Sales Market Share by Countries (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Sales Market Share by Countries in 2016
Table Europe Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2012-2017)
Table Europe Active Pharmaceutical Ingredients Revenue Market Share by Countries (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Revenue Market Share by Countries (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2016
Figure Germany Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure France Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure UK Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Russia Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Italy Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Sales (MT) by Type (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Market Share by Type (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Market Share by Type (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Sales (MT) by Applications (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Market Share by Applications (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Sales Market Share by Application in 2016
Table Middle East Active Pharmaceutical Ingredients Sales Volume (MT) by Countries (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Sales Volume Market Share by Countries in 2016
Table Middle East Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Revenue Market Share by Countries (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Revenue Market Share by Countries (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2016
Figure Saudi Arabia Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Israel Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure UAE Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Iran Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Active Pharmaceutical Ingredients Sales (MT) by Type (2012-2017)
Table Africa Active Pharmaceutical Ingredients Sales Market Share by Type (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Type (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Type in 2016
Table Africa Active Pharmaceutical Ingredients Sales (MT) by Application (2012-2017)
Table Africa Active Pharmaceutical Ingredients Sales Market Share by Application (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Application (2012-2017)
Table Africa Active Pharmaceutical Ingredients Sales Volume (MT) by Countries (2012-2017)
Table Africa Active Pharmaceutical Ingredients Sales Market Share by Countries (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Countries (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Countries in 2016
Table Africa Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2012-2017)
Table Africa Active Pharmaceutical Ingredients Revenue Market Share by Countries (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Revenue Market Share by Countries (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2016
Figure South Africa Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Table Pfizer Active Pharmaceutical Ingredients Basic Information List
Table Pfizer Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table Novartis International Active Pharmaceutical Ingredients Basic Information List
Table Novartis International Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis International Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Novartis International Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure Novartis International Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table Sanofi Active Pharmaceutical Ingredients Basic Information List
Table Sanofi Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure Sanofi Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Active Pharmaceutical Ingredients Basic Information List
Table Boehringer Ingelheim Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Basic Information List
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceutical Active Pharmaceutical Ingredients Basic Information List
Table Teva Pharmaceutical Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceutical Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company Active Pharmaceutical Ingredients Basic Information List
Table Eli Lilly and Company Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly and Company Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Active Pharmaceutical Ingredients Basic Information List
Table GlaxoSmithKline Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table Merck & Co Active Pharmaceutical Ingredients Basic Information List
Table Merck & Co Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure Merck & Co Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure Merck & Co Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table AbbVie Active Pharmaceutical Ingredients Basic Information List
Table AbbVie Active Pharmaceutical Ingredients Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbbVie Active Pharmaceutical Ingredients Sales (MT) and Growth Rate (2012-2017)
Figure AbbVie Active Pharmaceutical Ingredients Sales Market Share in EMEA (2012-2017)
Figure AbbVie Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Active Pharmaceutical Ingredients Basic Information List
Table Bayer Active Pharmaceutical Ingredients Basic Information List
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Basic Information List
Table DSM Active Pharmaceutical Ingredients Basic Information List
Table Hisun Pharmacy Active Pharmaceutical Ingredients Basic Information List
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients Basic Information List
Table North China Pharmaceutical Group Active Pharmaceutical Ingredients Basic Information List
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients Basic Information List
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients Basic Information List
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients Basic Information List
Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients Basic Information List
Table Lonza Group Active Pharmaceutical Ingredients Basic Information List
Table Aurobindo Pharma Active Pharmaceutical Ingredients Basic Information List
Table Lupin Active Pharmaceutical Ingredients Basic Information List
Table Biocon Active Pharmaceutical Ingredients Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients
Figure Active Pharmaceutical Ingredients Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2016
Table Major Buyers of Active Pharmaceutical Ingredients
Table Distributors/Traders List
Figure EMEA Active Pharmaceutical Ingredients Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Active Pharmaceutical Ingredients Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Active Pharmaceutical Ingredients Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2017-2022)
Table EMEA Active Pharmaceutical Ingredients Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2017-2022)
Table Europe Active Pharmaceutical Ingredients Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Active Pharmaceutical Ingredients Sales Market Share Forecast by Countries (2017-2022)
Table Europe Active Pharmaceutical Ingredients Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Active Pharmaceutical Ingredients Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Active Pharmaceutical Ingredients Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Active Pharmaceutical Ingredients Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Active Pharmaceutical Ingredients Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Active Pharmaceutical Ingredients Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Active Pharmaceutical Ingredients Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share Forecast by Countries (2017-2022)
Table Africa Active Pharmaceutical Ingredients Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Active Pharmaceutical Ingredients Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Active Pharmaceutical Ingredients Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2017-2022)
Table EMEA Active Pharmaceutical Ingredients Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
